Janux Therapeutics Inc

Research Janux Therapeutics Inc (JANX) on Bullrun: market cap USD 934.59M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerJANX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 934.59M
• Financial periodFY2025
• RevenueUSD 10.00M
• Revenue growth-5.6%
• Net income-USD 113.63M
• Free cash flow-USD 83.28M

Valuation Snapshot

latest market cap is USD 934.59M.

About Janux Therapeutics Inc

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms technology to treat patients with cancer.

Frequently asked questions

What is Janux Therapeutics Inc's market cap?

Janux Therapeutics Inc's market capitalization is USD 934.59M.

What does Janux Therapeutics Inc do?

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms technology to treat patients with cancer.